Palmitoylethanolamide protects against the amyloid-Β25-35-induced learning and memory impairment in mice, an experimental model of alzheimer disease

Neuropsychopharmacology

Volumn 37, Issue 7, 2012, Pages 1784-1792

  D'Agostino, Giuseppe ^a   Russo, Roberto ^a   Avagliano, Carmen ^a   Cristiano, Claudia ^a   Meli, Rosaria ^a   Calignano, Antonio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

dementia; fatty acid acyl ethanolamine; hippocampus; peroxisome proliferator activated receptors; water maze; Y maze

Indexed keywords

2 [4 [2 [3 CYCLOHEXYL 1 (4 CYCLOHEXYLBUTYL)UREIDO]ETHYL]PHENYLTHIO] 2 METHYLPROPIONIC ACID; AMYLOID BETA PROTEIN[25-35]; CASPASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; NEUROPROTECTIVE AGENT; PALMIDROL;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; EXPERIMENTAL TEST; LEARNING DISORDER; LIPID PEROXIDATION; MALE; MAZE TEST; MEMORY DISORDER; MENTAL PERFORMANCE; MOUSE; NEUROPROTECTION; NONHUMAN; OBJECT RECOGNITION TEST; PRIORITY JOURNAL; PROTEIN NYTROSYLATION; PROTEIN PROCESSING; SPATIAL MEMORY; WORKING MEMORY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; ETHANOLAMINES; LIPID PEROXIDATION; MAZE LEARNING; MEMORY DISORDERS; MEMORY, SHORT-TERM; MICE; PALMITIC ACIDS; PEPTIDE FRAGMENTS;

EID: 84861191772     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.25     Document Type: Article

References (41)

1. Bachur NR, Masek K, Melmon KL, Udenfriend S (1965). Fatty acid amides of ethanolamine in mammalian tissues. J Biol Chem 240: 1019-1024.
2. Bellinger FP, Madamba S, Siggins GR (1993). Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 628: 227-234.
3. Berger J, Moller DE (2002). The mechanisms of action of PPARs. Annu Rev Med 53: 409-435. (Pubitemid 34177889)
4. Cadas H, Schinelli S, Piomelli D (1996). Membrane localization of N-acylphosphatidylethonolamine in central neurons: studies with exogenous phospholipases. J Lipid Mediat Cell Signal 14: 63-70. (Pubitemid 26343339)
5. Calignano A, La Rana G, Giuffrida A, Piomelli D (1998). Control of pain initiation by endogenous cannabinoids. Nature 394: 277-281. (Pubitemid 28335039)
6. Calignano A, La Rana G, Piomelli D (2001). Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol 419: 191-198. (Pubitemid 32568218)
7. Cimini A, Benedetti E, D'Angelo B, Cristiano L, Falone S, Di Loreto S et al (2009). Neuronal response of peroxisomal and peroxisome- related proteins to chronic and acute Abeta injury. Curr Alzheimer Res 6: 238-251.
8. Coburn AF, Graham CE, Hahinger J (1954). Effect of egg yolk in diets on anaphylactic arthritis (passive Arthus phenomenon) in the guinea pig. J Exp Med 100: 425-435.
9. Coburn AF, Moore LV (1943). Nutrition as conditioning factor in the rheumatic state. Am J Dis Child 65: 744-756.
10. D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E et al (2009). Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. Eur J Pharmacol 613: 54-59.
11. D'Agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E et al (2007). Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferatoractivated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice. J Pharmacol Exp Ther 322: 1137-1143. (Pubitemid 47295805)
12. Delerive P, Fruchart JC, Staels B (2001). Peroxisome proliferatoractivated receptors in inflammation control. J Endocrinol 169: 453-459. (Pubitemid 32536978)
13. Delobette S, Privat A, Maurice T (1997). In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat. Eur J Pharmacol 319: 1-4. (Pubitemid 27051308)
14. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W (1996). The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384: 39-43.
15. Forman BM, Chen J, Evans RM (1996). The peroxisome proliferator-activated receptors: ligands and activators. Ann NY Acad Sci 804: 266-275. (Pubitemid 27056615)
16. Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodr?́guez De Fonseca F et al (2003). Oleoylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPARalpha. Nature 425: 90-93. (Pubitemid 37101723)
17. Gray E, Ginty M, Kemp K, Scolding N, Wilkins A (2011). Peroxisome proliferator-activated receptor-a agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function. Eur J Neurosci 33: 1421-1432.
18. Hort J, Laczó J, Vyhnálek M, Bojar M, Bures J, Vlcek K (2007). Spatial navigation deficit in amnestic mild cognitive impairment. Proc Natl Acad Sci USA 104: 4042-4047. (Pubitemid 47181575)
19. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ et al (1994). Differential expression and activation of a family of murine peroxisome proliferatoractivated receptors. Proc Natl Acad Sci USA 91: 7355-7359. (Pubitemid 24226862)
20. Kuehl Jr FA, Jacob TA, Ganley OH, Ormond RE, Meisinger MAP (1957). The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occurring anti-inflammatory agent. J Am Chem Soc 79: 5577-5578.
21. Lambert DM, Vandevoorde S, Diependaele G, Govaerts SJ, Robert AR (2001). Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice. Epilepsia 42: 321-327. (Pubitemid 32275910)
22. Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A et al (2005a). The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67: 15-19. (Pubitemid 40069962)
23. Long DA, Martin AJP (1956). Factor in arachis oil depressing sensitivity to tuberculin in B.C.G.-infected guinea pigs. The Lancet 267: 464-466.
24. LoVerme J, La Rana G, Russo R, Calignano A, Piomelli D (2005b). The search for the palmitoylethanolamide receptor. Life Sci 77: 1685-1698. (Pubitemid 41073662)
25. LoVerme J, Russo R, La Rana G, Fu J, Farthing J, Mattace-Raso G et al (2006). Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther 319: 1051-1061.
26. Masek K, Perlik F, Klima J, Kahlich R (1974). Prophylactic efficacy of N 2 hydroxyethyl palmitamide (Impulsin) in acute respiratory tract infections. Eur J Clin Pharmacol 7: 415-419.
27. Maurice T, Duclot F, Meunier J, Naert G, Givalois L, Meffre J et al (2008). Altered memory capacities and response to stress in p300/CBP-associated factor (PCAF) histone acetylase knockout mice. Neuropsychopharmacology 33: 1584-1602. (Pubitemid 351684713)
28. Maurice T, Lockhart BP, Privat A (1996). Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 706: 181-193. (Pubitemid 26048681)
29. Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A (1996). N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by downmodulating mast cell activation. Eur J Pharmacol 300: 227-236.
30. Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR et al (2008). Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. J Neurosci 28: 13985-13994.
31. Olariu A, Tran MH, Yamada K, Mizuno M, Hefco V, Nabeshima T (2001). Memory deficits and increased emotionality induced by beta-amyloid (25-35) are correlated with the reduced acetylcholine release and altered phorbol dibutyrate binding in the hippocampus. J Neural Transm 108: 1065-1079. (Pubitemid 32802103)
32. Raso GM, Esposito E, Vitiello S, Iacono A, Santoro A, D'Agostino G et al (2011). Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-a. J Neuroendocrinol 23: 591-600.
33. Sasso O, Russo R, Vitiello S, Mattace Raso G, D'Agostino G, Iacono A et al (2011). Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain. Pain 153: 33-41.
34. Schmid AW, Lynch MA, Herron CE (2009). The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo. Hippocampus 19: 670-676.
35. Scuderi C, Esposito G, Blasio A, Valenza M, Arietti P, Steardo Jr L et al (2011). Palmitoylethanolamide counteracts reactive astrogliosis induced by beta-amyloid peptide. J Cell Mol Med 15: 2664-2674.
36. Solorzano C, Zhu C, Battista N, Astarita G, Lodola A, Rivara S et al (2009). Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc Natl Acad Sci USA 106: 20966-20971.
37. Stellwagen D, Malenka RC (2006). Synaptic scaling mediated by glial TNF-alpha. Nature 440: 1054-1059.
38. Tsai SJ, Hong CJ, Liu ME, Hou SJ, Yen FC, Hsieh CH et al (2010). Interleukin-1 beta (C-511T) genetic polymorphism is associated with cognitive performance in elderly males without dementia. Neurobiol Aging 31: 1950-1955.
39. Willson TM, Brown PJ, Sternbach DD, Henke BR (2000). The PPARs: from orphan receptors to drug discovery. J Med Chem 43: 527-550. (Pubitemid 30127149)
40. Yamada K, Tanaka T, Han D, Senzaki K, Kameyama T, Nabeshima T (1999). Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)- induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 11: 83-90. (Pubitemid 29012313)
41. Zawia NH, Lahiri DK, Cardozo-Pelaez F (2009). Epigenetics, oxidative stress, and Alzheimer disease. Free Radic Biol Med 46: 1241-1249.